The Therapeutic Potential of ADSC-Secreted LEFTY2 in Treating Alzheimer’s Disease

Liwei Wu(Tzu Chi Foundation), Shinn‐Zong Lin(Tzu Chi University)

International Journal of Molecular Sciences

April 4, 2025

10.3390/ijms26073382

Cited by 1

Related Papers

Effects of incorporating multidomain interventions into integrated primary care on quality of life: a randomised controlled trial

|The Lancet Healthy Longevity|2021|90

C9-ALS-Associated Proline-Arginine Dipeptide Repeat Protein Induces Activation of NLRP3 Inflammasome of HMC3 Microglia Cells by Binding of Complement Component 1 Q Subcomponent-Binding Protein (C1QBP), and Syringin Prevents This Effect

|Cells|2022|26

Neuroprotective Capability of Narcissoside in 6-OHDA-Exposed Parkinson’s Disease Models through Enhancing the MiR200a/Nrf-2/GSH Axis and Mediating MAPK/Akt Associated Signaling Pathway

|Antioxidants|2022|20

Intramyocardial injection of human adipose-derived stem cells ameliorates cognitive deficit by regulating oxidative stress–mediated hippocampal damage after myocardial infarction

|Journal of Molecular Medicine|2021|13

PKC-δ-dependent mitochondrial ROS attenuation is involved as 9-OAHSA combats lipoapotosis in rat hepatocytes induced by palmitic acid and in Syrian hamsters induced by high-fat high-cholesterol high-fructose diet

|Toxicology and Applied Pharmacology|2023|13